title: Transseptal approach for the management of paravalvular regurgitation after transcatheter aortic valve replacement.
abstract: In the era of transcatheter aortic valve therapies, the presence of residual paravalvular regurgitation (PVR) after transcatheter aortic valve replacement (TAVR) may become a clinical challenge. Management of late symptomatic PVR is still unknown. We describe a challenging case of percutaneous closure attempt of a clinically significant PVR in a patient after Edwards SAPIEN (Edwards Lifesciences, CA) TAVR.
authors.affiliation: Elaine and Sydney Sussman Cardiac Catheterization Laboratory, University of Miami Hospital, Miller School of Medicine, Miami, Florida.
authors.forename: Claudia A
authors.initials: CA
authors.lastname: Martinez
authors.forename: Brian
authors.initials: B
authors.lastname: O'Neill
authors.forename: Vikas
authors.initials: V
authors.lastname: Singh
authors.forename: William W
authors.initials: WW
authors.lastname: O'Neill
mesh_terms: D000369:Aged, 80 and over; D001022:Aortic Valve Insufficiency / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D001024:Aortic Valve Stenosis / Q000175:diagnosis / Q000628:therapy*; D006328:Cardiac Catheterization / Q000009:adverse effects* / Q000295:instrumentation; D018618:Echocardiography, Doppler, Color; D017548:Echocardiography, Transesophageal; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects* / Q000295:instrumentation / Q000379:methods; D006801:Humans; D008297:Male; D015641:Radiography, Interventional; D055989:Septal Occluder Device; D012720:Severity of Illness Index; D016896:Treatment Outcome